EHAB
Enhabit, Inc.NYSEHealthcare$14.00+0.21%ClosedMarket Cap: $710.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.33
P/S
0.67
EV/EBITDA
13.50
DCF Value
$5.32
FCF Yield
9.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.9%
Operating Margin
6.0%
Net Margin
-0.4%
ROE
-0.8%
ROA
-0.4%
ROIC
-2.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $270.4M | 42.5% | $14.4M | $-38.7M | $-0.76 | — |
| FY 2025 | $1.06B | 46.9% | $63.8M | $-4.6M | $-0.09 | — |
| Q3 2025 | $263.6M | 48.5% | $16.8M | $11.1M | $0.22 | — |
| Q2 2025 | $266.1M | 46.9% | $16.7M | $5.2M | $0.10 | — |
| Q1 2025 | $259.9M | 49.9% | $15.9M | $17.8M | $0.35 | — |
| Q4 2024 | $258.2M | 48.5% | $-41.2M | $-46.0M | $-0.92 | — |
| FY 2024 | $1.03B | 48.7% | $-115.1M | $-156.2M | $-3.11 | — |
| Q3 2024 | $253.6M | 48.1% | $-98.0M | $-110.2M | $-2.20 | — |
| Q2 2024 | $260.6M | 46.5% | $11.2M | $-200.0K | $-0.00 | — |
| Q1 2024 | $262.4M | 45.9% | $12.9M | $200.0K | $0.00 | — |
| Q4 2023 | $260.6M | 45.8% | $4.9M | $-6.4M | $-0.13 | — |
| FY 2023 | $1.05B | 48.8% | $-47.6M | $-80.5M | $-1.61 | — |